U.S. market Open. Closes in 53 seconds

CNTX | Context Therapeutics Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue12.04K9.27KN/AN/AN/A
Gross Profit-12.04K-9.27KN/AN/AN/A
Operating Expenses25.07M14.88M7.44M2.57M5.38M
Selling, General & Admin7.29M7.79M3.63M930.67K2.97M
Research & Development17.78M7.09M3.81M1.64M2.41M
Other Operating Expenses0-2.00K123.87K9.88M93.36K
Operating Income-25.07M-15.38M-10.53M-2.57M-5.38M
Other Expenses / Income1.11M545.26K68.95K9.22M-1.01M
Before Tax Income-23.96M-14.84M-10.46M6.64M-6.38M
Income Tax ExpensesN/A-545.26K-3.02M661.22K1.10M
Net Income-23.96M-14.29M-7.43M6.64M-7.48M
Interest ExpensesN/A547.27K64.24K661.22K1.10M
Basic Shares Outstanding15.97M15.97M15.97M10.96M10.96M
Diluted Shares Outstanding15.97M15.97M15.97M10.96M10.96M
EBITDA-25.06M-14.83M-10.53MN/AN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-23.96M-14.29M-10.39M7.97M-5.28M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙